title: Genetic content of Influenza H3N2 vaccine seeds.
abstract: Influenza vaccine seeds produced in chicken eggs are selected through HA and NA surface glycoproteins antigenicity, as well as through high replicative ability. Here we characterize the genetic content of recently used thirteen H3N2 influenza vaccine seeds. Interestingly, sequence analysis of the vaccine seeds shows reassortment events leading to PR8:H3N2 segment constellations, ranging from the 6:2 to 2:6 constellations. This study shows that the H3N2 PB1 is the most frequent internal segment incorporated in the tested vaccines seeds.
authors.affiliation: Université; Lyon 1; CNR Virus Influenza région sud - Hospices Civils de Lyon; NIC Lyon & UCBL-CNRS FRE 3011, Lyon, and VirPath FRE3011, Université Lyon1, France.
authors.forename: Corinne
authors.initials: C
authors.lastname: Bergeron
authors.forename: Martine
authors.initials: M
authors.lastname: Valette
authors.forename: Bruno
authors.initials: B
authors.lastname: Lina
authors.forename: Michele
authors.initials: M
authors.lastname: Ottmann
references.citation: PLoS One. 2009 May 21;4(5):e5658
references.pmid: 19462010
references.citation: Proc Natl Acad Sci U S A. 2005 Nov 15;102(46):16825-9
references.pmid: 16267134
references.citation: Nat Rev Immunol. 2007 Apr;7(4):267-78
references.pmid: 17363960
references.citation: J Virol. 1976 May;18(2):738-44
references.pmid: 944790
references.citation: J Virol. 1996 Oct;70(10):6653-7
references.pmid: 8794300
references.citation: Arch Virol. 1980;64(2):171-3
references.pmid: 7387405
references.citation: J Virol. 2008 Dec;82(23):11880-8
references.pmid: 18815312
references.citation: J Vet Med Sci. 1999 Aug;61(8):987-9
references.pmid: 10487248
references.citation: J Virol. 2000 Sep;74(18):8709-19
references.pmid: 10954572
references.citation: Curr Top Microbiol Immunol. 2004;283:313-42
references.pmid: 15298174
references.citation: Vaccine. 2009 Oct 30;27(46):6460-3
references.pmid: 19559113
references.citation: Vaccine. 2005 Apr 22;23(22):2943-52
references.pmid: 15780743
references.citation: Vaccine. 2009 Apr 28;27(19):2588-93
references.pmid: 19428865
references.citation: Virology. 1979 May;95(1):269-74
references.pmid: 442543
references.citation: Curr Top Microbiol Immunol. 2004;283:43-60
references.pmid: 15298167
references.citation: J Virol. 2008 Mar;82(5):2295-304
references.pmid: 18094182
references.citation: Influenza Other Respir Viruses. 2007 Jan;1(1):5-9
references.pmid: 19459278
references.citation: J Virol. 2004 Sep;78(17):9144-53
references.pmid: 15308710
references.citation: J Virol. 2002 Feb;76(4):1781-6
references.pmid: 11799173
references.citation: Vaccine. 2003 May 1;21(16):1776-9
references.pmid: 12686093
references.citation: Vaccine. 1999 Apr 9;17(15-16):1942-50
references.pmid: 10217593
references.citation: Proc Natl Acad Sci U S A. 2009 Jul 14;106(28):11709-12
references.pmid: 19597152
references.citation: Arch Virol. 2001 Dec;146(12):2275-89
references.pmid: 11811679